Enfield Development Finance: 1 Unit Residential Scheme at 49 Tynemouth Drive Enfield EN1 4LR Enters the Pipeline

A fresh application has landed on the London Borough of Enfield planning register for 49 Tynemouth Drive, Enfield, EN1 4LR. Reference 26/03238/FUL was received on 30 July 2026 and is pending decision, per the borough's Idox planning system. The proposal is a change of use from a standard dwelling house, Use Class C3, to a house in multiple occupation, Use Class Sui Generis, with associated cycle and refuse storage. The physical works are modest by borough standards: a single storey rear extension, a rear dormer and front rooflights, delivering one additional unit on the plot.

This is exactly the type of scheme our desk sees a lot of in Enfield at the moment. HMO conversions sit in a sweet spot for smaller sponsors: the planning risk is lower than a full redevelopment because the building envelope is largely retained, but the change of use still needs a lender who understands Sui Generis consent and how it affects exit valuation. We estimate the gross development value on completion at £445,000, based on our own modelling against the scale and location of the scheme, and that figure is what most lenders will want to see stress tested before they commit terms.

Enfield's residential pipeline has been busy through 2026, and this application adds to a steady run of small scale HMO and conversion projects across the borough, from Ponders End through to Bush Hill Park. Sponsors working in this postcode range should expect competition for build contractors and for finance slots, particularly where a scheme needs to complete before year end. We track applications like this one as part of our ongoing coverage of the borough, and readers wanting the wider picture on values, completions and lending activity in the area can see our Enfield development finance hub for context on how this scheme fits into the broader local market.

On the funding side, a single unit HMO conversion of this size typically needs a short term development or bridging facility to cover the build cost, followed by either a term refinance onto an HMO investment product or a straight sale exit. Specialist commercial lenders and bridging specialists are usually the best fit here rather than mainstream high street banks, because Sui Generis use classes and small unit counts can fall outside standard lending criteria. Loan to GDV will be the number that matters most once planning is granted, and with our estimate sitting at £445,000, we would expect facility sizes to be modest but the underwriting to still hinge on a clean exit strategy.

Our read as brokers is straightforward. If consent is granted on the timeline we would normally expect for a scheme of this scope, the sponsor should already be lining up a funding line rather than waiting for the decision notice to land. Challenger banks and specialist lenders active in the HMO space will want sight of the change of use application, a realistic build cost schedule and a clear exit plan before they issue terms, and getting that conversation started early tends to shave weeks off completion once planning comes through. We will keep watching this application and the wider Enfield pipeline as it moves toward a decision.